Zhao Shaoyong, Lv Tao, Gong Guang, Wang Changsong, Huang Bin, Zhou Wenhao
Department of General Surgery, No. 2 People's Hospital of Yibin City, Yibin, China.
J Laparoendosc Adv Surg Tech A. 2013 Jan;23(1):43-7. doi: 10.1089/lap.2012.0388. Epub 2012 Dec 18.
To investigate the feasibility, effectiveness, and safety of a combination therapy of laparoscopic splenectomy (LS) with pericardial devascularization (PD) (laparoscopic Hassab's procedure) with or without limited portacaval shunt (LPS) for patients with portal hypertension due to liver cirrhosis.
During September 2008 to April 2012, 42 patients underwent a combined treatment of LS with PD in our hospital. Of these subjects, 16 patients had an assessment of free portal vein pressure of more than 3.92-4.4 kPa and underwent a further limited LPS. Information on patients' demographics, diagnosis, and indication of splenectomy and perioperative variables was collected and analyzed.
All patients successfully survived the operation, and 2 patients required an intraoperative conversion to open splenectomy because of intraoperative bleeding. For patients with LS plus PD, the mean operating time was 145 minutes, and the estimated blood loss was 146.2 mL. For patients who received an additional LPS, the total operating time was 232 minutes, and the established blood loss was 338.1 mL. The mean postoperative hospital stay was 11.7 and 12.3 days, respectively. Postoperative complications occurred in 1 patient who suffered gastric leakage, who received a re-operation and recovered later, and in 5 patients who experienced ascites, who received conserved medical treatment. During the follow-up, 2 patients had esophageal variceal bleeding 3 months and 1 year, respectively, after surgery. One patient had an encephalopathy 1 year after surgery, and 2 patients suffered a portal vein thrombosis without any clinical symptom. All of them were treated with conservation therapy. Two patients died 24-36 months and more than 36 months after surgery, because of liver failure. The other patients recovered well.
We concluded that being only slightly invasive, the sandwich strategy treatment of LS with PD and LPS is feasible, effective, and safe for patients with portal hypertension due to liver cirrhosis.
探讨腹腔镜脾切除术(LS)联合心包血管离断术(PD)(腹腔镜哈萨布手术)加或不加限制性门腔分流术(LPS)治疗肝硬化门静脉高压症患者的可行性、有效性和安全性。
2008年9月至2012年4月,我院42例患者接受了LS联合PD治疗。其中16例患者门静脉自由压评估超过3.92 - 4.4kPa,并进一步接受了限制性LPS。收集并分析患者的人口统计学信息、诊断、脾切除术指征及围手术期变量。
所有患者手术均成功存活,2例因术中出血需术中转为开腹脾切除术。对于接受LS加PD的患者,平均手术时间为145分钟,估计失血量为146.2mL。对于接受额外LPS的患者,总手术时间为232分钟,确定失血量为338.1mL。术后平均住院时间分别为11.7天和12.3天。术后并发症发生在1例胃漏患者,该患者接受了再次手术并随后康复,以及5例腹水患者,这些患者接受了保守治疗。随访期间,2例患者分别在术后3个月和1年发生食管静脉曲张出血。1例患者术后1年发生脑病,2例患者发生门静脉血栓形成但无任何临床症状。所有这些患者均接受保守治疗。2例患者分别在术后24 - 36个月和超过36个月因肝功能衰竭死亡。其他患者恢复良好。
我们得出结论,对于肝硬化门静脉高压症患者,LS联合PD和LPS的三明治策略治疗仅具有轻微侵袭性,是可行、有效且安全的。